Literature DB >> 3358888

Relative bioavailability of the hydrochloride, sulphate and ethyl carbonate salts of quinine.

A Jamaludin1, M Mohamad, V Navaratnam, K Selliah, S C Tan, W H Wernsdorfer, K H Yuen.   

Abstract

The hydrochloride, sulphate and ethylcarbonate salts of quinine were given in single oral doses (600 mg base equivalent) to nine healthy male subjects according to a cross-over design. No statistically significant differences were noted in the plasma drug concentration-time profiles although inter- and intra-subject variation in AUC, Cmax and tmax values was appreciable. The ethylcarbonate salt may be preferred for use in paediatric patients because of its neutral taste.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3358888      PMCID: PMC1386482          DOI: 10.1111/j.1365-2125.1988.tb03299.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  1 in total

1.  The bioavailability of quinine.

Authors:  J C Garnham; K Raymond; E Shotton; P Turner
Journal:  J Trop Med Hyg       Date:  1976-12
  1 in total
  9 in total

1.  Effect of dose size on the pharmacokinetics of orally administered quinine.

Authors:  A Sowunmi; L A Salako
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

2.  The reproducibility of quinine bioavailability.

Authors:  G Paintaud; G Alván; O Ericsson
Journal:  Br J Clin Pharmacol       Date:  1993-03       Impact factor: 4.335

3.  Disposition of oral quinine in acute falciparum malaria.

Authors:  W Supanaranond; T M Davis; S Pukrittayakamee; K Silamut; J Karbwang; P Molunto; L Chanond; N J White
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

4.  Disposition of quinine in plasma, red blood cells and saliva after oral and intravenous administration to healthy adult Africans.

Authors:  L A Salako; A Sowunmi
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 5.  Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications.

Authors:  S Krishna; N J White
Journal:  Clin Pharmacokinet       Date:  1996-04       Impact factor: 6.447

Review 6.  Treatment of malaria--1990.

Authors:  D M Panisko; J S Keystone
Journal:  Drugs       Date:  1990-02       Impact factor: 9.546

7.  Marked enhancement by rifampicin and lack of effect of isoniazid on the elimination of quinine in man.

Authors:  S Wanwimolruk; W Kang; P F Coville; S Viriyayudhakorn; S Thitiarchakul
Journal:  Br J Clin Pharmacol       Date:  1995-07       Impact factor: 4.335

8.  Pharmacokinetics of quinine in African patients with acute falciparum malaria.

Authors:  C P Babalola; O O Bolaji; F A Ogunbona; A Sowunmi; O Walker
Journal:  Pharm World Sci       Date:  1998-06

9.  Incorporation of physiologically based pharmacokinetic modeling in the evaluation of solubility requirements for the salt selection process: a case study using phenytoin.

Authors:  Po-Chang Chiang; Harvey Wong
Journal:  AAPS J       Date:  2013-08-14       Impact factor: 4.009

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.